In the News
Life Singularity Utilizes AI to Identify Infectious Disease Patterns for Scalable Covid-19 Surveillance and Community Preparedness - (17 June 2020)
Life Singularity is leveraging AI and comprehensive data analysis to identify relevant communicable disease patterns...
Life Singularity's Early Identification of Vulnerable Patient Populations Helps with Proactive Response to Pandemic - (17 June 2020)
Life Singularity’s focus on AI-driven prevention will facilitate early Covid-19 detection in vulnerable populations, allowing for reduced healthcare costs and lower risk of new outbreaks...
Life Singularity's Industry-Leading AI Addresses Social Determinants of Health - (17 June 2020)
Using proprietary AI and social determinants of health, Life Singularity has identified socioeconomic disparities that impact Covid-19 patient outcomes...
Life Singularity Launches COVID-19 Community Vulnerability Surveillance Map - (17 June 2020)
Life Singularity is pleased to announce the development of the Covid Community Vulnerability Map. This geospatial map is intended as an easily accessible resource...
Life Singularity Introduces AI_VR - Enabled Autonomous Monitoring Platform For Employer Recovery to Facilitate Safe Reopening of States and Businesses - (17 June 2020)
Life Singularity has recently launched a comprehensive AI/VR-enabled Employer Recovery Platform designed to help states and businesses reopen safely...
EY's Entrepreneur-of-the-Year Strategic Growth Forum
Life Singularity, Inc. was privileged and honored to be included in the 2,000 of the country's most ambitious CEOs and entrepreneurs attending EY's exclusive Entrepreneur-of-the-Year (EOY) Strategic Growth Forum® SGFUS in Palm Springs, CA, last week. Congratulations to all the winners!
Huge thanks to many of those ambitious leaders who want to collaborate on disrupting the health system with our AI/VR platform
Pictured: Carl Armato, Yele Aluko MD, MBA, FACC, FSCAI., John Thero, James Maida, Michael Kalb, Jim Nixon, Victor Hwang, Gerry Dixon, Michael Praeger, Laura Anderson, Kathy Harris, Marc Lederman, Kendall O'Brien, Ambar Boodhoo, Phani Tipparaju, Ian Michelich, Brian Beard, Ben Lamm, Kangyi Mao, Akram Boutros, MD, Rebecca Ditmer, Stash Lisowski, Tom Meredith, Carole Faig, Evan Nawrocki, J.D. LaRock, J.D., Ed.D., Jim Kenny, John Geyer, John Latham, Nancy Conturso, Ashish Kachru, Raj Thiagarajan, Margot Carter, Monika J. Wilczak, Steve Mitchell, Jessel Mendes, Hari Chenglath, Andrew Gilbert, Chevenry Arnold, Alex Shahidi
Huge thanks to my EOYUS hosts Michael J. Kacsmar and Debra von Storch for their incredible support
Real Leaders Podcast: Predicting Disease Before It Happens
Life Singularity was honored to be invited to the Real Leaders podcast. The interview by Kevin Edwards premiered at XMed. Fantastic to share my mission, vision and purpose for creating an AI/VR platform for global social impact on health.
Exponential Medicine 2019 Healthcare Information Lab
Life Singularity, Inc. was honored to be a part of the Exponential Medicine 2019 Healthcare Information Lab. Thank you Daniel Kraft, and a million thanks to those who listened to our story and to those who want to explore moonshot collaborations!
Pictured: Carl Armato, Yele Aluko MD, MBA, FACC, FSCAI., John Thero, James Maida, Michael Kalb, Jim Nixon, Victor Hwang, Gerry Dixon, Michael Praeger, Laura Anderson, Kathy Harris, Marc Lederman, Kendall O'Brien, Ambar Boodhoo, Phani Tipparaju, Ian Michelich, Brian Beard, Ben Lamm, Kangyi Mao, Akram Boutros, MD, Rebecca Ditmer, Stash Lisowski, Tom Meredith, Carole Faig, Evan Nawrocki, J.D. LaRock, J.D., Ed.D., Jim Kenny, John Geyer, John Latham, Nancy Conturso, Ashish Kachru, Raj Thiagarajan, Margot Carter, Monika J. Wilczak, Steve Mitchell, Jessel Mendes, Hari Chenglath, Andrew Gilbert, Chevenry Arnold, Alex Shahidi
Ep. 47: All-in-One Virtual Health Assistant - Sanjeev Wadhwa (CEO Life Singularity)
Sanjeev Wadhwa, Founder and CEO of Life Singularity. Life singularity is a startup looking to ultimately create A Virtual Assistant for every individual on the planet using AI/VR/blockchain to drive precision health.
Health Tech Austin - The AI & Blockchain Summit
Come see our CEO, Sanjeev Wadhwa, at the AI & Blockchain Summit on July 18!
https://lnkd.in/dt7JmKX.
Join Life Singularity in “Netflixing Limitless AI-enabled Health to Massive communities”
Current Applications and Future of AI in Cardiology
Excited about AI in Cardiology Mayo Clinic event
Visit us - Joint exhibit of Life Singularity, Inc., and EY Todd Schack Laura Guerin Howard, Yele Aluko MD, MBA, FACC, FSCAI. in predictive health. Looking forward to seeing Suraj Kapa, Eric Topol, MD, Vinod Khosla, and Paul Friedman. Thank You Mayo Clinic!
Had a great time at AI in Cardiology Mayoclinic event this past weekend!
Huge thanks to EY Global for support and Mayo Clinic, Dr.Paul Friedman, and Suraj Kapa for the invite! Excited to be driving the future of predictive health.
Sanjeev Wadhwa, CEO of Life Singularity, will be moderating a panel on AI/Blockchain @BIO 2019 on:
Bitcoin your data! From Trusted Pharma Silos to Trustless Community-owned Blockchain-based Precision Medicine Data Trials
As care for lifestyle-driven chronic diseases expands in scope, prevention and recovery are becoming the new focus areas. Building a precision medicine foundation that will promote ownership of individuals’ health data and allow for sharing and trading of this data, could be great use case for Blockchain. At its core, blockchain would offer the potential of a shared platform that decentralizes healthcare interactions ensuring access control, authenticity, and integrity, while presenting the industry with radical possibilities for value-based care and reimbursement models.
So, are we off to a “trustless” information model underpinned by Bitcoin cryptocurrency, where no central authority validates the transactions in the ledger, and anyone whose computers can do the required math can join to mine and add blocks to your data? Would smart contracts begin to incentivize “rational” behaviors where consumers respond in a manner that makes their data interesting? Let the games begin!
Our panel of experts explores how blockchain technology could provide an additional layer of trust and security to potentially eliminate the inherent challenges for precision medicine practice, such as health data interoperability, cybersecurity, data ownership, and value-based care. It will explore blockchain foundational properties with a differential value proposition to address some of the pressing needs for precision medicine practice.
Kamal Obbad, CEO and Co-Founder, Nebula Genomics; David Koepsell, Founder and CEO, Encrypgen, @drkoepsell; Katherine Kuzmeskas, CEO, SimplyVital Health; John Kamara, CEO Alpha Health; James Canterbury, Principal, EY; @ObbadKamal, @kkuzmesk, @JJkamara, @drkoepsell @BIOConvention @Bitcoin @BTC @Blockchain #Blockchain #AI #innovation #startup #digitalhealth #healthtech #innovators http://bit.ly/2P4v29c
Sanjeev Wadhwa, CEO of Life Singularity, will be moderating a #BrainMachine panel @BIO 2019 on:
The Mind-Body Electric: Brain-Body Plasticity, Bioelectricity and Breakthrough Therapies
Mind-body research began moving into the mainstream over a decade ago and it’s commonly understood that the mind affects the body and vice versa. Neuroplasticity is now considered a given as a plethora of research has shown that our brains, given the right circumstances, can indeed rewire themselves, and more cutting edge research has revealed that other non-neural systems can be brought to bear when needed as well.
New disciplines of psychoneuroimmunology and explorations of the gut microbiome on mental health are rapidly expanding and giving rise to new approaches to some of the most intractable disorders of the brain. In addition, today there is surge of new bioelectrical treatments being cleared by regulatory agencies and in clinical trials for everything from treating chronic pain and serious mental illness including depression, anxiety, bi-polar and schizophrenia, to pediatric TBI and autism, and even stroke recovery and dementia rehab. In the challenging realm of brain health where pharmaceuticals have seen noteworthy and expensive failures – the next wave of treatments and cures may be coming from one of these novel sources.
Our panel of experts will discuss recent research, the favorable regulatory environment and new business models around the electrifying new wave of potential for novel brain-body therapeutics.
Life Singularity #BrainHealth panel at #BIO2019 on "The Mind-Body Electric: Brain-Body Plasticity, Bioelectricity and Breakthrough Therapies" 2019 BIO Intl Convention @niraxxlife @eQuility_net @IVinvents @RHanbury @SarahMidMO @healiumXR @StoryUpstudios @BrainHealth #Neurotech #AI #innovation #startup #vr #ar #digitalhealth #healthtech #innovators 2019 @BIOConvention June 4 in Philadelphia
Dr. Paolo Cassano MD. PhD., Harvard Medical School, Massachusetts General Hospital, Co-Founder Niraxx Therapeutics, @niraxxlife; Sarah Hill, CEO of StoryUP XR, @SarahMidMo; Roy Levien, Co-Founder and Chief Digital Officer, eQuility, @eQuility_net; Richard Hanbury, CEO Sana Health @Rhanbury attending; @BIOConvention @BrainHealth #Neurotech #AI #innovation #startup #vr #ar #digitalhealth #healthtech #innovators
Sanjeev Wadhwa, CEO of Life Singularity, will be moderating a panel on AI/Blockchain @BIO 2019 on:
Bitcoin your data! From Trusted Pharma Silos to Trustless Community-owned Blockchain-based Precision Medicine Data Trials
As care for lifestyle-driven chronic diseases expands in scope, prevention and recovery are becoming the new focus areas. Building a precision medicine foundation that will promote ownership of individuals’ health data and allow for sharing and trading of this data, could be great use case for Blockchain. At its core, blockchain would offer the potential of a shared platform that decentralizes healthcare interactions ensuring access control, authenticity, and integrity, while presenting the industry with radical possibilities for value-based care and reimbursement models.
So, are we off to a “trustless” information model underpinned by Bitcoin cryptocurrency, where no central authority validates the transactions in the ledger, and anyone whose computers can do the required math can join to mine and add blocks to your data? Would smart contracts begin to incentivize “rational” behaviors where consumers respond in a manner that makes their data interesting? Let the games begin!
Our panel of experts explores how blockchain technology could provide an additional layer of trust and security to potentially eliminate the inherent challenges for precision medicine practice, such as health data interoperability, cybersecurity, data ownership, and value-based care. It will explore blockchain foundational properties with a differential value proposition to address some of the pressing needs for precision medicine practice.
Kamal Obbad, CEO and Co-Founder, Nebula Genomics; David Koepsell, Founder and CEO, Encrypgen, @drkoepsell; Katherine Kuzmeskas, CEO, SimplyVital Health; John Kamara, CEO Alpha Health; James Canterbury, Principal, EY; @ObbadKamal, @kkuzmesk, @JJkamara, @drkoepsell @BIOConvention @Bitcoin @BTC @Blockchain #Blockchain #AI #innovation #startup #digitalhealth #healthtech #innovators http://bit.ly/2P4v29c
Life Singularity enters Google's Cloud Program for Startups
Basking Ridge, NJ — November 1, 2018 — Life Singularity, Inc., offering a breakthrough predictive health AI platform, is thrilled to announce its acceptance into the Google Cloud Platform Startup Program, joining a select group of Healthcare AI companies that utilize Google Cloud Platform within their product offerings.
Life Singularity is excited and privileged to be working with Google using the Google Cloud Platform (GCP) for Startups program, designed to help startups build and scale. Life Singularity will leverage the Google Cloud Platform to reveal insights about the precision health allowing us to make quick and accurate predictions about predictive health trajectories. Life Singularity analyzes the behavome and exposome to gain invaluable insights about individualized health, the environmental exposures and emotional well-being. Our first release of the AI/VR platform offers individualized health predictions across 14 chronic diseases across the medicare populations; based on an 3-year and 15-year historical backtest, we’re now predicting the individualized health trajectories faster and more accurately than the individualized baselines.
With Google Cloud Platform, we benefited by having those computational resources that have been made available to Life Singularity, The startup program has provided us a great opportunity to evaluate Cloud Platform services such as Google Container Engine, Google Container Registry, Google BigQuery and Google Cloud Monitoring, tailor our deployment on Compute Engine or leverage Google Kubernetes Engine for deploying containerize applications. all of which we can now use with our customers.
Life Singularity is excited and privileged to be working with Google using the Google Cloud Platform (GCP) for Startups program, designed to help startups build and scale. Life Singularity will leverage the Google Cloud Platform to reveal insights about the precision health allowing us to make quick and accurate predictions about predictive health trajectories. Life Singularity analyzes the behavome and exposome to gain invaluable insights about individualized health, the environmental exposures and emotional well-being. Our first release of the AI/VR platform offers individualized health predictions across 14 chronic diseases across the medicare populations; based on an 3-year and 15-year historical backtest, we’re now predicting the individualized health trajectories faster and more accurately than the individualized baselines.
With Google Cloud Platform, we benefited by having those computational resources that have been made available to Life Singularity, The startup program has provided us a great opportunity to evaluate Cloud Platform services such as Google Container Engine, Google Container Registry, Google BigQuery and Google Cloud Monitoring, tailor our deployment on Compute Engine or leverage Google Kubernetes Engine for deploying containerize applications. all of which we can now use with our customers.
Google was very generous to give us a capacity to scale. Most importantly for a small startup like us with dreams to change the world is the partnership we intend to form with the GCP technical team. Google truly went out of its way to help us get up and running and maximize the value of the platform. We look forward to working with the Google team to push the limits of predicting human health.
Being accepted into Google's Cloud Platform Startup Program is a strong indication of our future direction and investments into AI for delivering real-time precision health. Google and GCP have been a major part of the growth and success of great AI companies like Pipeline AI, PIXLEE, Camio, Vaultedge, and many others. We are proud to be a part of that impressive group. It’s an exciting time in AI in healthcare right now, and it is nice to know that we’ve made it onto the radar of a company like Google, and the partners they work with in the Google Cloud program like NVIDIA, venture partners, and others. With AI as its pillar, this is further confirmation that Life Singularity is on the right path to disrupt healthcare.”
Through the Google Cloud Platform Startup Package, Life Singularity will invest in its real-time predictive health AI platform for the next year. Thank you Google!
Life Singularity enters Amazon's #AWSActivate Program by Amazon Web Services
Basking Ridge, NJ — May 11, 2018 — Life Singularity, Inc., offering a breakthrough predictive health AI platform, is thrilled to announce its acceptance into the AWS Activate program, joining a select group of Healthcare AI companies that utilize Amazon Web Services within their product offerings.
At Life Singularity, we have had a deep love and respect for the startup community. Along this journey with our original team, we’ve worked with our trusted advisors and mentors. In particular, startup programs such as the NVIDIA AI Inception program have been integral to our growth as a company— and the credits from those programs are instrumental in getting our infrastructure up and running.
At Life Singularity, we have had a deep love and respect for the startup community. Along this journey with our original team, we’ve worked with our trusted advisors and mentors. In particular, startup programs such as the NVIDIA AI Inception program have been integral to our growth as a company— and the credits from those programs are instrumental in getting our infrastructure up and running.
Now, we are excited to expand our role within the AI startup community through AWS Activate. AWS Activate helps companies to grow just as we have grown, by providing startups with the resources needed to get started on Amazon Web Services, creating a community for collaboration and sharing of best practices, and supports growth and success for its member companies.
“This is quite an honor for us,” said Sanjeev Wadhwa, Chief Executive Officer for Life Singularity, Inc. “Being accepted into AWS Activate is a strong indication of our future direction and investments into AI for delivering real-time precision health. AWS and AWS Activate have been a major part of the growth and success of great AI companies like GRAIL, Lyft, Slack, Twilio, Etsy, AirBnB, and many others. We are proud to be a part of that impressive group. It’s an exciting time in AI in healthcare right now, and it is nice to know that we’ve made it onto the radar of a company like Amazon Web Services, and the partners they work with in the AWS Activate program like NVIDIA, venture partners, and others. With AI as its pillar, this is further confirmation that Life Singularity is on the right path to disrupt healthcare.”
Through the AWS Activate Portfolio Plus Package, Life Singularity will invest in its real-time predictive health AI platform for the next year. Thank you Amazon!
Life Singularity will have access to exclusive support and training resources, special offers from third-parties, and subsidies for expansion of their platform within Amazon Web Services. These benefits will further speed Life Singularity's expansion of products and services, and promote additional offerings to existing customers and partners as well as aiding in the pursuit of even more opportunities.
GTC 18 Deeplearning AI Conference - Nvidia AI Inception Program
Jensen's Keynote highlighted where #AI-VR is now evolving to 3D Volumetric segmentation, 3 layers of inception in #VR for Human Teleportation using Nvidia Holodeck to Project Clara for medical imaging (cinematic rendering to 15 year old ultrasound, CT, MRI, and PET scans) and #deeplearning models growing in effectiveness at a double exponential.
"Data is the new source code" says Jensen and I couldn't agree more.
Life Singularity, Inc., is a proud member of the NVIDIA AI Inception Program (@NvidiaAI Inception Program). #AIInception
Life Singularity gains cutting-edge technology and access to experts through the @NvidiaAI Inception Program.
Sanjeev Wadhwa, CEO of Life Singularity, will be moderating a #BrainMachine panel @BIO 2018 on:
Digital Doses of Electricity and Neural Pacemakers – Tapping, Zapping, Hacking and Mapping the Nervous System through pioneering Bioelectronic Nerve Implants and Neural AI to stop chronic disease
Imagine curing patients with electrons instead of drugs!
In a future informed by Neural #AI, #deeplearning, and bioelectronic medicine , if we can properly analyze the electronic data the body circulates, physicians may be able to learn of abnormalities and risks before their patients are conscious of them. Bioelectronic medicine is an emerging frontier, and an alternative to molecular medicine, where biology and electronics are converging to create a new generation of therapies with so much potential, that some wonder if they will eventually replace pharmaceuticals altogether
Life Singularity #BrainMachine panel at #BIO2018 on "Digital Doses of Electricity and Neural Pacemakers – Tapping, Zapping, Hacking and Mapping the Nervous System through pioneering Bioelectronic Nerve Implants and Neural AI to stop chronic disease" June 5, 2018 in Boston - https://bit.ly/2qd6D57
@EBoyden3, Co-Dir, MIT Neurobiological Engg; Michel Maharbiz @ucbeecs, Co-Inventor of Neural Dust; @ChadBouton, Inventor of Neurobridge, VP, @NorthwellHealth; JP Errico, Chief Science & Strategy Officer, @ElectroCoreVNS attending; @BIOConvention @BrainHealth #Neurotech #AI
Sanjeev Wadhwa, CEO of Life Singularity, moderated a panel @BIO 2017 on:
Empathetic AI: AI-Powered Empathetic Virtual Humans and Brain-Machine Interfaces Delivering Virtual Therapies in Virtual Worlds
Our esteemed panel included Virtual Reality Pioneer, Dr. Walter Greenleaf, Stanford Virtual Human Interaction Lab; Physician Visionary, Dr. Skip Rizzo, Director for Medical Virtual Reality Institute at USC Institute for Creative Technologies, and Chris Chin, Sr. Director for VR Content at HTC Vive
Sanjeev Wadhwa, CEO of Life Singularity, moderated a panel @BIO 2015 on:
The Internet of Everything meets Digital Health
Our esteemed panel included (Left to Right) Brandon Staglin, Patient and Innovator, One Mind Institute; Jack Hidary, Google X Labs Advisory Board; Don Jones, Chief Executive Officer at Trial Fusion and Allen Lalonde, Sr. Executive, IBM Canada Research & Development Center
Sanjeev Wadhwa, CEO of Life Singularity, moderated a panel @BIO 2015 on:
Precision Medicine: Revolutionizing today’s Healthcare
Our esteemed panel included Dr. Felix Frueh, PhD, Chief Scientific Officer, Human Longevity, Inc., John L. Brooks III, President and CEO, Joslin Diabetes Center, Craig Lipset, Head of Clinical Innovation at Pfizer, and Sanjiv S. Agarwala, MD, Professor of Medicine, Chief, Oncology & Hematology St. Luke's University Hospital and Temple Univ
Sanjeev Wadhwa, CEO of Life Singularity, speaker and panelist at the Fifth Annual Value-Based Cancer Care Conference, June 2015
“Data in Motion” Will Promote Patient-Centric Care Models
Our esteemed panel included Alex Jung, Principal in the Global Strategic Advisory Services practice of Ernst & Young